| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |